Patents by Inventor Hangming Dong

Hangming Dong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating HIF-1a over-expressing cancers
    Patent number: 11359008
    Abstract: Described herein are compositions that include monoclonal antibodies that specifically bind Hsp90? and methods of using the same to treat HIF-1a-overexpressing cancer. In some embodiments, the cancers are breast cancer or lung cancer. The monoclonal antibodies bind the epitope TKPIWTRNP in Hsp90? or VKHFSVEGQ in Hsp90?.
    Type: Grant
    Filed: April 4, 2019
    Date of Patent: June 14, 2022
    Assignee: University of Southern California
    Inventors: Wei Li, David Woodley, Mei Chen, Divya Sahu, Hangming Dong, Mengchen Zou
  • COMPOSITIONS AND METHODS FOR TREATING HIF-1a OVER-EXPRESSING CANCERS
    Publication number: 20200392213
    Abstract: Described herein are compositions that include monoclonal antibodies that specifically bind Hsp90? and methods of using the same to treat HIF-1?-overexpressing cancer. In some embodiments, the cancers are breast cancer or lung cancer. The monoclonal antibodies bind the epitope TKPIWTRNP in Hsp90? or VKHFSVEGQ in Hsp90?.
    Type: Application
    Filed: April 4, 2019
    Publication date: December 17, 2020
    Applicant: University of Southern California
    Inventors: Wei Li, David Woodley, Mei Chen, Divya Sahu, Hangming Dong, Mengchen Zou
  • Compositions and methods for treating HIF-1? over-expressing cancers
    Patent number: 10273294
    Abstract: Described herein are compositions that include monoclonal antibodies that specifically bind Hsp90? and methods of using the same to treat HIF-1?-overexpressing cancer. In some embodiments, the cancers are breast cancer or lung cancer. The monoclonal antibodies bind the epitope TKPIWTRNP (SEQ ID NO: 1) in Hsp90? or VKHFSVEGQ (SEQ ID NO: 2) in Hsp90?.
    Type: Grant
    Filed: November 4, 2015
    Date of Patent: April 30, 2019
    Assignee: University of Southern California
    Inventors: Wei Li, David Woodley, Mei Chen, Divya Sahu, Hangming Dong, Mengchen Zou
  • COMPOSITIONS AND METHODS FOR TREATING HIF-1a OVER-EXPRESSING CANCERS
    Publication number: 20160053003
    Abstract: Described herein are compositions that include monoclonal antibodies that specifically bind Hsp90? and methods of using the same to treat HIF-1a-overexpressing cancer. In some embodiments, the cancers are breast cancer or lung cancer. The monoclonal antibodies bind the epitope TKPIWTRNP in Hsp90? or VKHFSVEGQ in Hsp90?.
    Type: Application
    Filed: November 4, 2015
    Publication date: February 25, 2016
    Applicant: UNIVERSITY OF SOUTHERN CALIFORNIA
    Inventors: Wei Li, David Woodley, Mei Chen, Divya Sahu, Hangming Dong, Mengchen Zou